Nijmegen, The Netherlands – Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, has announced a collaboration with Physiogenex, a leading preclinical Contract...

Nijmegen, Netherlands – Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, announced the introduction of its NephroPath platform. By partnering with Aiosyn,...

DDW’s Megan Thomas speaks to Jennifer Cann, Director of Pathology at Virscio, a company solving human health challenges through biomedical research.  MT: Can you provide a top line summary of your research?  JC: As Virscio’s...

Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development 27 April 2023 at 12:00 a.m. EEST. Aiforia has received a funding...

Digital pathology solutions are increasingly used in the preclinical and clinical development phases, particularly toxicologic pathology and clinical trials, speeding up the process and curtailing expenses. SAN ANTONIO, Feb. 15,...

LAUSANNE, Switzerland & TEL AVIV, Israel--(BUSINESS WIRE)--Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Nucleai, a leader in AI-powered spatial biology transforming...